BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wray NH, Rasenick MM. NMDA-receptor independent actions of ketamine: a new chapter in a story that's not so old. Neuropsychopharmacology 2019;44:220-1. [PMID: 30214059 DOI: 10.1038/s41386-018-0201-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Witkin JM, Martin AE, Golani LK, Xu NZ, Smith JL. Rapid-acting antidepressants. Neuropsychotherapeutics. Elsevier; 2019. pp. 47-96. [DOI: 10.1016/bs.apha.2019.03.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
2 Moaddel R, Zanos P, Farmer CA, Kadriu B, Morris PJ, Lovett J, Acevedo-diaz EE, Cavanaugh GW, Yuan P, Yavi M, Thomas CJ, Park LT, Ferrucci L, Gould TD, Zarate CA. Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration. Transl Psychiatry 2022;12. [DOI: 10.1038/s41398-022-01941-x] [Reference Citation Analysis]
3 Venturino A, Siegert S. Minimally invasive protocols and quantification for microglia-mediated perineuronal net disassembly in mouse brain. STAR Protoc 2021;2:101012. [PMID: 34950889 DOI: 10.1016/j.xpro.2021.101012] [Reference Citation Analysis]
4 Shaffer CL, Dutra JK, Tseng WC, Weber ML, Bogart LJ, Hales K, Pang J, Volfson D, Am Ende CW, Green ME, Buhl DL. Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine. Neuropharmacology 2019;153:73-81. [PMID: 31015046 DOI: 10.1016/j.neuropharm.2019.04.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]